Literature DB >> 2187599

Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products.

S J Meltzer1, S M Mane, P K Wood, J H Resau, C Newkirk, J A Terzakis, B I Korelitz, W M Weinstein, S W Needleman.   

Abstract

Activation of c-Ki-ras by point mutation within exon 1 was studied in 33 specimens of dysplastic gastrointestinal lesions or of cancers presumed to arise from dysplasia. Samples were obtained from patients with underlying ulcerative colitis or Barrett's esophagus, two diseases associated with dysplasia and increased rates of colonic or esophageal adenocarcinoma, respectively. Genomic DNA was amplified using primers bounding this exon in the polymerase chain reaction. Polymerase chain reaction products were analyzed by direct dideoxy sequencing. Three point mutations in codon 13 of c-Ki-ras were found, all in colonic specimens (two high-grade dysplasias and one adenocarcinoma arising in ulcerative colitis). No point mutations were observed in the second exon of c-Ki-ras or in and around codons 12, 13, and 61 of c-N-ras and C-Ha-ras in a partial sampling of the specimens. These data indicate that ras family protooncogene activation is an uncommon event at this level of malignant progression in these disease states. Carcinogenesis in ulcerative colitis and Barrett's esophagus may proceed via different pathways than in sporadic colon cancer, perhaps involving loss or inactivation of suppressor genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187599

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

2.  In situ amplification of single copy gene segments in individual cells by the polymerase chain reaction.

Authors:  W Spann; K Pachmann; H Zabnienska; A Pielmeier; B Emmerich
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

Review 3.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

4.  Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.

Authors:  S J Meltzer; J Yin; Y Huang; T K McDaniel; C Newkirk; O Iseri; B Vogelstein; J H Resau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 5.  Molecular biology of colorectal neoplasia.

Authors:  N Scott; P Quirke
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

6.  Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps.

Authors:  T T Wu; B Rezai; A Rashid; M C Luce; M C Cayouette; C Kim; N Sani; L Mishra; C A Moskaluk; J H Yardley; S R Hamilton
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

7.  K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.

Authors:  P Chaubert; J Benhattar; E Saraga; J Costa
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells.

Authors:  Chunhua Yu; Qiuyang Zhang; Hui Ying Zhang; Xi Zhang; Xiaofang Huo; Edaire Cheng; David H Wang; Jack L Arbiser; Stuart Jon Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-28       Impact factor: 4.052

9.  Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease.

Authors:  R J Alexander; A Panja; E Kaplan-Liss; L Mayer; R F Raicht
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

10.  Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.

Authors:  C A Cartwright; C A Coad; B M Egbert
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.